# Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD

> **NCT06220474** · NA · RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 112 (estimated)

## Conditions studied

- Dry Eye Syndromes
- Meibomian Gland Dysfunction

## Interventions

- **DEVICE:** The Thermage FLX System
- **DEVICE:** Sham treatment

## Key facts

- **NCT ID:** NCT06220474
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-22
- **Primary completion:** 2027-10-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06220474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06220474, "Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06220474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*